Back to top
Read MoreHide Full Article

Industrial gas producer and supplier, Praxair Inc. (PX - Free Report) recently priced $900 million worth of notes, offered under the company’s universal shelf registration statement. The offering will consummate on Feb 21, 2013.

The current notes issuance will be given effect through the issuing of $400 million of 0.75% notes due in 2016 and $500 million of 2.70% notes due in 2023, expected to yield 0.771% and 2.740% on maturity, respectively. The offer price for 0.75% notes has been fixed at 99.938% of principal amount while at 99.652% for 2.70% notes.

Interest on these notes will be paid semi-annually with the first payment falling due on August 21, 2013. Praxair intends to use the proceeds from the issuance for repaying short-term debt, repurchase of shares, acquisitions and for general corporate purposes.

Prior to this issue, Praxair had raised $700 million in November 2012, $500 million in August 2012 and $600 million in February 2012.

Exiting 2012, Praxair’s long-term debt balance stood at $6,685.0 million, up 4.6% sequentially. Interest paid during the year totaled $141 million. Rising debt burden will increase the company’s financial obligations all the more in the quarters ahead.

The current Zacks Consensus Estimate for the first quarter of 2013 is $1.39, representing a year-over-year increase of 0.4%. Estimates for years 2013 and 2014 are $6.00 and $6.82, reflecting annual growth of 7.7% and 13.6%, respectively.

The stock currently carries a Zacks Rank #3 (Hold). Other stocks to watch out for in the industry are Arkema S.A. (ARKAY - Free Report) , with a Zacks Rank #1 (Strong Buy) and BASF SE (BASFY - Free Report) and Air Products & Chemicals Inc. (APD - Free Report) , each with a Zacks Rank #2 (Buy).

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BASF SE (BASFY) - free report >>

Praxair, Inc. (PX) - free report >>

Air Products and Chemicals, Inc. (APD) - free report >>

Arkema SA (ARKAY) - free report >>

More from Zacks Analyst Blog

You May Like